Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
|ClinicalTrials.gov Identifier: NCT00547066|
Recruitment Status : Unknown
Verified March 2016 by Immunomedics, Inc..
Recruitment status was: Active, not recruiting
First Posted : October 19, 2007
Last Update Posted : March 21, 2016
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||December 2016|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Liebman HA, Saleh MN, Bussel JB, Negrea OG, Horne H, Wegener WA, Goldenberg DM. Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia. Haematologica. 2016 Nov;101(11):1327-1332. Epub 2016 Aug 11.